We are live on
!
Find out more
TAM
TFG Asset Management Portfolio holdings
AUM
$509M
1-Year Est. Return
24.47%
This Fund
S&P 500
This Quarter
Est. Return
+10.01%
1 Year Est. Return
+24.47%
3 Year Est. Return
+54.92%
5 Year Est. Return
+65.34%
10 Year Est. Return
+105.07%
AUM
$554M
AUM Growth
+$243M
(+78%)
Cap. Flow
+$11.3M
Cap. Flow
% of AUM
2.03%
Top 10 Holdings %
Top 10 Hldgs %
84.43%
Holding
40
New
7
Increased
12
Reduced
4
Closed
3
Top Buys
| 1 |
UiPath
PATH
|
+$57.3M |
| 2 |
Workiva
WK
|
+$10.3M |
| 3 |
Scholar Rock
SRRK
|
+$3.25M |
| 4 |
Tarsus Pharmaceuticals
TARS
|
+$3.22M |
| 5 |
Dyne Therapeutics
DYN
|
+$1.52M |
Top Sells
| 1 |
INFA
Informatica
INFA
|
+$14M |
| 2 |
Compañía de Minas Buenaventura
BVN
|
+$867K |
| 3 |
OTLY
Oatly Group
OTLY
|
+$798K |
| 4 |
Keros Therapeutics
KROS
|
+$743K |
| 5 |
Cameco
CCJ
|
+$108K |
Sector Composition
| 1 | Technology | 40.13% |
| 2 | Healthcare | 13.37% |
| 3 | Energy | 9.04% |
| 4 | Materials | 0.3% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
UiPath
PATH
$6.19B
| $176M | 31.68% |
13,722,244
+4,772,244
| +53% | +$57.3M |
|
|
KGEI
2
Kolibri Global Energy
KGEI
$182M
| $48.7M | 8.78% |
7,068,857
-1,711
| -0% | -$11.8K |
|
|
AUTL
3
Autolus Therapeutics
AUTL
$402M
| $21.7M | 3.91% |
9,500,000
+900,000
| +10% | +$1.49M |
|
4
Sprinklr
CXM
$1.35B
| $18.6M | 3.36% |
2,200,000
| – | – |
|
5
Lyft
LYFT
$6.16B
| $15.8M | 2.84% |
1,000,000
| – | – |
|
|
6
Workiva
WK
$3.05B
| $10.3M | 1.85% |
+150,000
| New | +$10.3M |
|
|
7
Tarsus Pharmaceuticals
TARS
$2.51B
| $10.1M | 1.83% |
250,000
+71,530
| +40% | +$3.22M |
|
8
Annexon
ANNX
$1.06B
| $6.74M | 1.22% |
2,810,000
+160,000
| +6% | +$321K |
|
9
Celldex Therapeutics
CLDX
$3.01B
| $6.43M | 1.16% |
316,150
+55,150
| +21% | +$1.07M |
|
10
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
| $5.54M | 1% |
68,660
+5,518
| +9% | +$435K |
|
|
TECX
11
Tectonic Therapeutic
TECX
$613M
| $4.55M | 0.82% |
228,832
+41,332
| +22% | +$838K |
|
12
Axsome Therapeutics
AXSM
$12.2B
| $4.34M | 0.78% |
41,531
+7,725
| +23% | +$818K |
|
|
13
Scholar Rock
SRRK
$6.48B
| $3.67M | 0.66% |
+103,482
| New | +$3.25M |
|
14
Acadia Pharmaceuticals
ACAD
$4.44B
| $3.48M | 0.63% |
161,396
+54,396
| +51% | +$1.01M |
|
15
Pharvaris
PHVS
$2.46B
| $3.31M | 0.6% |
188,100
+61,105
| +48% | +$984K |
|
16
Relay Therapeutics
RLAY
$4.25B
| $2.42M | 0.44% |
699,000
+80,000
| +13% | +$238K |
|
17
Immunovant
IMVT
$8.19B
| $2.37M | 0.43% |
147,817
+16,650
| +13% | +$252K |
|
18
Snowflake
SNOW
$94.2B
| $2.24M | 0.4% |
10,000
| – | – |
|
|
19
Keros Therapeutics
KROS
$218M
| $1.71M | 0.31% |
128,000
-55,000
| -30% | -$743K |
|
|
20
Cameco
CCJ
$39.6B
| $1.43M | 0.26% |
19,280
-2,020
| -9% | -$108K |
|
21
Amylyx Pharmaceuticals
AMLX
$1.98B
| $1.4M | 0.25% |
+218,750
| New | +$1.06M |
|
|
22
Dyne Therapeutics
DYN
$3.97B
| $1.32M | 0.24% |
+138,375
| New | +$1.52M |
|
23
Hudbay
HBM
$9.76B
| $1.14M | 0.2% |
107,000
| – | – |
|
24
Alkermes
ALKS
$8.66B
| $447K | 0.08% |
+15,632
| New | +$465K |
|
25
Sociedad Química y Minera de Chile
SQM
$20.4B
| $272K | 0.05% |
+7,700
| New | +$263K |
|
Similar funds
HNW
MCA
OA
PWMG
MC
WDG
B
OWP